Galapagos NV Profile Avatar - Palmy Investing

Galapagos NV

Galapagos NV, an integrated biopharmaceutical company, engages in the discovery, development, and commercialization of various medicines for high unmet medical need. Its pipeline products include filgotinib, a JAK1 inhibitor that is in various phases of …
Biotechnology
BE, Mechelen [HQ]
Competitors · Subsidiaries · Locations

Context Analysis

U.S. · Business Intelligence
Worldwide · Business Intelligence
Worldwide · Competitors Table
Competitor Private? Source Accuracy Country City
- - - -
Worldwide · Subsidiaries Table
Subsidiary Private? Country City
- - - -
End of GLPGF's Analysis
CIK: 1421876 CUSIP: - LEI: - UEI: -
Secondary Listings